Literature DB >> 26746434

Cerebral malaria--clinical manifestations and pathogenesis.

Rachna Hora1, Payal Kapoor2, Kirandeep Kaur Thind2, Prakash Chandra Mishra3.   

Abstract

One of the most common central nervous system diseases in tropical countries is cerebral malaria (CM). Malaria is a common protozoan infection that is responsible for enormous worldwide mortality and economic burden on the society. Episodes of Plasmodium falciparum (Pf) caused CM may be lethal, while survivors are likely to suffer from persistent debilitating neurological deficits, especially common in children. In this review article, we have summarized the various symptoms and manifestations of CM in children and adults, and entailed the molecular basis of the disease. We have also emphasized how pathogenesis of the disease is effected by the parasite and host responses including blood brain barrier (BBB) disruption, endothelial cell activation and apoptosis, nitric oxide bioavailability, platelet activation and apoptosis, and neuroinflammation. Based on a few recent studies carried out in experimental mouse malaria models, we propose a basis for the neurological deficits and sequelae observed in human cerebral malaria, and summarize how existing drugs may improve prognosis in affected individuals.

Entities:  

Keywords:  Cerebral malaria; Cytoadherence; Neuroinflammation; Neurological deficits

Mesh:

Substances:

Year:  2016        PMID: 26746434     DOI: 10.1007/s11011-015-9787-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  135 in total

1.  Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria.

Authors:  Irene Gramaglia; Peter Sobolewski; Diana Meays; Ramiro Contreras; John P Nolan; John A Frangos; Marcos Intaglietta; Henri C van der Heyde
Journal:  Nat Med       Date:  2006-11-12       Impact factor: 53.440

2.  Perfusion abnormalities in children with cerebral malaria and malarial retinopathy.

Authors:  Nicholas A V Beare; Simon P Harding; Terrie E Taylor; Susan Lewallen; Malcolm E Molyneux
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

3.  Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital, Uganda.

Authors:  Richard Idro; Charles Karamagi; James Tumwine
Journal:  Ann Trop Paediatr       Date:  2004-03

4.  Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells.

Authors:  Samuel Crocodile Wassmer; Catherine Lépolard; Boubacar Traoré; Bruno Pouvelle; Jürg Gysin; Georges Emile Grau
Journal:  J Infect Dis       Date:  2004-01-09       Impact factor: 5.226

5.  Complications and mortality patterns due to Plasmodium falciparum malaria in hospitalized adults and children, Rourkela, Orissa, India.

Authors:  Sanjib Mohanty; Saroj K Mishra; Sudhansu S Pati; Jayakrushna Pattnaik; Bhabani S Das
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Jan-Feb       Impact factor: 2.184

Review 6.  Malaria and the red cell.

Authors:  David J Weatherall; Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo; Climent Casals-Pascual; David J Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

7.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

8.  Elevated plasma von Willebrand factor and propeptide levels in Malawian children with malaria.

Authors:  Happy T Phiri; Daniel J Bridges; Simon J Glover; Jan A van Mourik; Bas de Laat; Bridon M'baya; Terrie E Taylor; Karl B Seydel; Malcolm E Molyneux; E Brian Faragher; Alister G Craig; James E G Bunn
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

Review 9.  Microparticles: a new perspective in central nervous system disorders.

Authors:  Stephanie M Schindler; Jonathan P Little; Andis Klegeris
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

10.  Neurological sequelae in survivors of cerebral malaria.

Authors:  Isaac Oludare Oluwayemi; Biobele Joackim Brown; Olusola Adetunji Oyedeji; Margaret Adefiola Oluwayemi
Journal:  Pan Afr Med J       Date:  2013-07-06
View more
  20 in total

1.  Rocaglates as dual-targeting agents for experimental cerebral malaria.

Authors:  David Langlais; Regina Cencic; Neda Moradin; James M Kennedy; Kodjo Ayi; Lauren E Brown; Ian Crandall; Michael J Tarry; Martin Schmeing; Kevin C Kain; John A Porco; Jerry Pelletier; Philippe Gros
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

2.  Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral Malaria.

Authors:  Dibyadyuti Datta; Andrea L Conroy; Peter F Castelluccio; John M Ssenkusu; Gregory S Park; Robert O Opoka; Paul Bangirana; Richard Idro; Andrew J Saykin; Chandy C John
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

Review 3.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

Review 4.  Brain diseases in changing climate.

Authors:  Joanna A Ruszkiewicz; Alexey A Tinkov; Anatoly V Skalny; Vasileios Siokas; Efthimios Dardiotis; Aristidis Tsatsakis; Aaron B Bowman; João B T da Rocha; Michael Aschner
Journal:  Environ Res       Date:  2019-08-08       Impact factor: 6.498

Review 5.  Genetics of cerebral malaria: pathogenesis, biomarkers and emerging therapeutic interventions.

Authors:  Lydia Nkuah Nortey; Alberta Serwah Anning; Gideon Kwesi Nakotey; Abdala Mumuni Ussif; Yeboah Kwaku Opoku; Silas Acheampong Osei; Benjamin Aboagye; George Ghartey-Kwansah
Journal:  Cell Biosci       Date:  2022-06-17       Impact factor: 9.584

6.  α-Tocopheryl succinate-suppressed development of cerebral malaria in mice.

Authors:  Aiko Kume; Shunji Kasai; Hana Furuya; Hiroshi Suzuki
Journal:  Parasitol Res       Date:  2018-07-20       Impact factor: 2.289

Review 7.  Vaccinations for Neuroinfectious Disease: A Global Health Priority.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

8.  Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes.

Authors:  Xianzhu Wu; Kiran K Dayanand; Ramesh P Thylur; Christopher C Norbury; D Channe Gowda
Journal:  J Biol Chem       Date:  2017-07-05       Impact factor: 5.157

9.  Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.

Authors:  Kristina S Burrack; Matthew A Huggins; Emily Taras; Philip Dougherty; Christine M Henzler; Rendong Yang; Sarah Alter; Emily K Jeng; Hing C Wong; Martin Felices; Frank Cichocki; Jeffrey S Miller; Geoffrey T Hart; Aaron J Johnson; Stephen C Jameson; Sara E Hamilton
Journal:  Immunity       Date:  2018-04-03       Impact factor: 43.474

Review 10.  Protective and Pathological Immunity during Central Nervous System Infections.

Authors:  Robyn S Klein; Christopher A Hunter
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.